Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q2 FY26 results · Jul–Sep 2025
Amrutanjan Health Care reported revenue from operations of ₹117.70 crore (up 7.1% from Q2 FY25) and net profit of ₹13.96 crore (up 18.4% from Q2 FY25) for Q2 FY26 (Jul–Sep 2025), on a standalone basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 117.70 | 109.92 | +7.1% | 94.05 | +25.2% |
| Other income | 4.30 | 4.05 | +6.2% | 4.43 | −3.0% |
| Total income | 122.00 | 113.96 | +7.0% | 98.47 | +23.9% |
| Profit before tax | 19.21 | 15.94 | +20.5% | 11.29 | +70.2% |
| Net profit for the period | 13.96 | 11.80 | +18.4% | 8.31 | +68.0% |
| EPS, basic (₹) | 4.83 | 4.08 | +18.4% | 2.87 | +68.3% |
| Net margin (%) | 11.9 | 10.7 | 8.8 |
Standalone
- Filed with BSE
- 10 Nov 2025, 18:35 IST
- Board meeting
- 10 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE